GU Cast | Urology Podcast Podcast Por Professor Declan Murphy & Dr Renu Eapen arte de portada

GU Cast | Urology Podcast

GU Cast | Urology Podcast

De: Professor Declan Murphy & Dr Renu Eapen
Escúchala gratis

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

A urology podcast, focussing on prostate cancer, kidney cancer, bladder cancer, testis and penile cancer. Join Professor Declan Murphy and Dr Renu Eapen from Peter MacCallum Cancer Centre in Melbourne for this regular dive into the world of genitourinary (GU) Oncology and Urology. Regular guests from all over the world, from every walk of life. Find out more gucast.org

© 2025 GU Cast | Urology Podcast
Ciencia Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Journal Club #5 | Lamm BCG maintenance and CHAARTED
    Jan 9 2026

    Happy New Year and welcome to Episode 5 of our monthly GU Cast Journal Club! Today we focus on two classic papers in non-invasive bladder cancer and metastatic prostate cancer. The Lamm RCT of maintenance BCG is a landmark trial for all sorts of reasons, published in J Urol in 2000. And the CHAARTED paper of chemohormonal therapy is the landmark trial of combination therapy in mHSPC, published in NEJM in 2015.

    We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne, AUS), and Dr Elena Berg (Munich, GER), along with main GU Cast Hosts, Renu Eapen and Declan Murphy. A very lively discussion!!

    Links to papers below:
    1. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study J Urol 2000

    2. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    NEJM 2015

    GU Cast Journal Club is supported by our Partner, MSD, through an unrestricted educational grant.

    Even better on our YouTube channel

    About GU Cast Journal Club:
    Each month, two papers are discussed, each of which are of importance to the GU Oncology community. These may be recent papers, or occasionally we will chose a classic landmark paper in GU Oncology
    . The objective is to draw attention to important papers in GU Oncology, and critique these in a robust manner
    . The key target audience is trainees working in Urology, Medical Oncology, Radiation Oncology, Nuclear Medicine, and diagnostic specialties such as Radiology and Pathology. But any of our regular audience are likely to enjoy this Journal Club series.

    Más Menos
    31 m
  • Focus on China | ESMO prostate cancer highlights
    Dec 4 2025

    Another of our special Themed Podcasts focussed on prostate cancer in China, supported by our Gold Partner, Bayer. We are joined as ever by our China Editor, Dr Yao Zhu (Fudan University Shanghai Cancer Centre), and also special guest Dr Yige Bao (SCU Xiamen Hospital). Not only do we learn about pandas in West China, but also some great highlights from the recent ESMO Annual Meeting in Berlin! Hosted as ever by Dr Renu Eapen and Prof Declan Murphy


    Even better on our YouTube channel

    Más Menos
    40 m
  • Journal Club #4 | PRECISION and EB-StaR
    Nov 30 2025

    Episode 4 of our monthly GU Cast Journal Club and today we focus on two important papers in prostate cancer diagnostics and bladder cancer surgery. The PRECISION NEJM paper 2018 is a landmark publication which defined the role of mpMRI in early detection, and changed practice in many countries. The EB-StaR trial should also change practice after its European Urology 2024 publication, but has it??!

    We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne, AUS), and Dr Elena Berg (Munich, GER), along with main GU Cast Hosts, Renu Eapen and Declan Murphy. A very lively discussion!!

    Links to papers below:
    1. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis NEJM 2018

    2. Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial Eur Urol 2024

    GU Cast Journal Club is supported by our Partner, MSD, through an unrestricted educational grant.

    Even better on our YouTube channel

    About GU Cast Journal Club:

    Each month, two papers are discussed, each of which are of importance to the GU Oncology community. These may be recent papers, or occasionally we will chose a classic landmark paper in GU Oncology
    . The objective is to draw attention to important papers in GU Oncology, and critique these in a robust manner
    . The key target audience is trainees working in Urology, Medical Oncology, Radiation Oncology, Nuclear Medicine, and diagnostic specialties such as Radiology and Pathology. But any of our regular audience are likely to enjoy this Journal Club series.

    Más Menos
    32 m
Todavía no hay opiniones